by Elizabeth Kissling | Apr 22, 2010 | Birth Control, Disposable menstrual products, Menstruation, New Research, Pharmaceutical
So here’s an odd little study: when women are given a choice between oral contraceptives and the contraceptive vaginal ring, what characteristic is most highly correlated with a slightly greater interest in using the vaginal ring? If you said “tampon...
by Elizabeth Kissling | Apr 19, 2010 | Menopause, New Research, Newspapers, Pharmaceutical
Guest Post by Jerilynn C. Prior, Centre for Menstrual Cycle and Ovulation Research I just read “The Estrogen Dilemma” in Sunday’s New York Times Magazine, and I feel like weeping—in sorrow and deep sadness. This article by Cynthia Gorney is about energetic,...
by Elizabeth Kissling | Apr 18, 2010 | Menopause, New Research, Newspapers, Pharmaceutical
Guest Post by Paula S. Derry, Ph.D. Déjà vu An article in today’s New York Times Magazine recounts the author’s experience with a debilitating depression that began during her perimenopause, the transitional time leading up to menopause. For her, prescription...
by Chris Bobel | Apr 12, 2010 | Anatomy, New Research
Guest Post by Alexandra Jacoby “Controversy Rages Over Female Genital Cosmetic Surgery”. You can read the full article by Betsy Bates in Ob.Gyn. News. Bates interviews doctors as to whether performing these procedures meets a need or exploits a lack of body-knowledge...
by Elizabeth Kissling | Apr 10, 2010 | Menstruation, New Research, Reusable menstrual products
A small study published this month in the Journal of Obstetrics & Gynaecology tested effectiveness of the mooncup. The results won’t surprise anyone who has used one: “The Mooncup leaked 0.5 times less frequently and required to be changed 2.8 times...
by Elizabeth Kissling | Apr 3, 2010 | Birth Control, Menstruation, New Research, Pharmaceutical
We’ve mentioned Yaz and its sister drug Yasmin before, and our friend Holly Grigg-Spall tracks the progress of complaints against them and other oral contraceptives. Yaz and Yasmin were Bayer’s top-selling drugs in 2008, bringing in about $1.8 billion, a 17...
